Padcev 20 mg
Padcev 20 mg is a medicine authorised by Swissmedic under authorisation number 68291. The authorisation holder is Astellas Pharma AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 09 November 2021 and the authorisation is valid without a time limit. ATC code L01FX13 places the medicine in the group Antineoplastic agents.
| Authorisation number | 68291 |
|---|---|
| Name | Padcev 20 mg |
| Full name | Padcev 20 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Astellas Pharma AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01FX13 |
| First authorisation | 09 November 2021 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 3 | Padcev 20 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung | A | 09 November 2021 |
| 4 | Padcev 30 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung | A | 09 November 2021 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01FX13 | 07.16.1. | A |
| 2 | 1 | Durchstechflasche(n) | L01FX13 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Padcev 20 mg authorised in Switzerland?
Yes. Padcev 20 mg is authorised by Swissmedic under authorisation number 68291, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Padcev 20 mg have?
Padcev 20 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Padcev 20 mg?
The authorisation holder is Astellas Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.